What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label study
International Clinical Psychopharmacology,  Clinical Article

Shim G et al. – These results imply that doses less than or equal to 40 mg/day ESC are sufficient for symptomatic improvement with good tolerability for most patients. Very high doses of ESC, on the other hand, can be considered for patients with inadequate therapeutic responses to the administration of 40 mg/day ESC.

Methods

  • Explored efficacy and tolerability of very high doses (maximum dose of >40 mg/day), high doses (maximum dose of 25–40 mg/day), and standard doses (maximum dose of ≤20 mg/day) of escitalopram (ESC) as an anti-obsessive–compulsive disorder treatment in a naturalistic clinical setting
  • Reviewed medical records of all patients with OCD (n=246) who had taken ESC between May 2006 and September 2009, and assigned Clinical Global Impression (CGI) scores
  • Of total sample, 24.4, 38.2, and 37.4% patients received very high, high, and standard doses of ESC, and the mean daily maximum doses of ESC were 57.3±12.0 mg, 33.9±5.4 mg, and 13.4±5.8 mg

Results
  • CGI-Severity scores in each group decreased significantly after treatment with ESC, as evidenced by response rates (i.e. CGI-Improvement scores of 1 or 2) of 46.3, 43.2, and 26.2%

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

2 Blood manganese levels in relation to comorbid behavioral and emotional problems in children with attention-deficit/hyperactivity disorder Psychiatry Research, November 4, 2014    Clinical Article

3 Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study International Journal of Epidemiology, November 18, 2014    Clinical Article

4 The influence of inflammatory cytokines in physiopathology of suicidal behavior Journal of Affective Disorders, November 5, 2014    Evidence Based Medicine    Review Article

5 Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases Paediatric and Perinatal Epidemiology, November 12, 2014    Clinical Article

6 Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: A systematic review and meta-analysis of randomized clinical trials JAMA Psychiatry, October 22, 2014    Evidence Based Medicine    Clinical Article

7 Birth by caesarean section and development of autism spectrum disorder and attention-deficit/hyperactivity disorder: A systematic review and meta-analysis Journal of Child Psychology and Psychiatry, November 19, 2014    Evidence Based Medicine

8 Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness Psychiatry Research, November 10, 2014    Clinical Article

9 Is depression associated with increased oxidative stress?: A systematic review and meta-analysis Psychoneuroendocrinology, November 7, 2014    Evidence Based Medicine

10 Obesity and major depression: Body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations Psychoneuroendocrinology, November 6, 2014    Clinical Article

11 Serum dehydroepiandrosterone sulfate and incident depression in the elderly: The Pro.V.A Study The American Journal of Geriatric Psychiatry, November 24, 2014    Clinical Article

12 Effects of perinatal mental disorders on the fetus and child The Lancet, November 21, 2014    Evidence Based Medicine    Clinical Article

13 Antidepressant–induced sexual dysfunction during treatment with fluoxetine, sertraline, and trazodone: A randomized controlled trial General Hospital Psychiatry, November 7, 2014    Clinical Article

14 The serotonin-N-acetylserotonin–melatonin pathway as a biomarker for autism spectrum disorders Full Text Translational Psychiatry, November 26, 2014    Free full text    Clinical Article

15 Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period The Lancet, November 20, 2014    Evidence Based Medicine

16 Comparative efficacy and acceptability of drug treatments for bipolar depression: A multiple-treatments meta-analysis Acta Psychiatrica Scandinavica, October 10, 2014    Evidence Based Medicine    Clinical Article

17 Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction Comprehensive Psychiatry, November 13, 2014    Clinical Article

18 Specific and common genes implicated across major mental disorders: A review of meta-analysis studies Journal of Psychiatric Research, November 17, 2014    Review Article

19 Association between toll-like receptors expression and major depressive disorder Psychiatry Research, November 11, 2014    Clinical Article

20 The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial Psychiatry Research, November 4, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore